Latest Belimumab Stories

2008-07-24 09:01:14

ROCKVILLE, Md., July 24 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced that David P. Southwell has been appointed to the HGS Board of Directors. He will also serve as a member of the Company's Audit Committee. Until recently, Mr. Southwell was at Sepracor, Inc., a research-based pharmaceutical company, where he served as Executive Vice President and Chief Financial Officer, and also had responsibility for Corporate Planning, Development and Licensing. (Logo:...

2006-08-09 08:00:00

BOSTON - Biotechnology company Human Genome Science Inc. said on Wednesday that it plans shortly to seek approval from U.S. regulators to run a late-stage clinical trial of its drug to treat systemic lupus erythematosus, a chronic, life-threatening disease. If the U.S. Food and Drug Administration approves Human Genome's proposal for the design of its Phase III clinical trial, the company could begin enrollment by the end of this year. This is the first time Human Genome Sciences has brought...

2004-11-30 09:00:10

ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. announced today that it has completed the enrollment and initial dosing of patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced non- small cell lung cancer. The multi-center, open-label, single-arm Phase 2 clinical trial is designed to evaluate the efficacy, safety and tolerability of HGS-ETR1 in patients with relapsed or refractory...

Word of the Day
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'